Nuo Therapeutics, Inc. (AURX) stock

AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30

$1.26−0.04 (-3.08%)

Close on Oct 19, 2026Market cap $61.08MP/E –Yield –

Nuo Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2014 it was $0, down 100.0% from the year before. The highest annual figure on record is $3.62M in fiscal 2013.

Period	Period end	Value	Change
FY2014	Dec 31, 2014	$0	-100.0%
FY2013	Dec 31, 2013	$3.62M	+72.4%
FY2012	Dec 31, 2012	$2.10M	0.0%
FY2011	Dec 31, 2011	$2.10M	+6.0%
FY2010	Dec 31, 2010	$1.98M	–

Parsed from the XBRL in Nuo Therapeutics's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is AURX.

Revenue growth131.1% · median 60.7%

Gross margin64.6% · median 63.2%

Operating margin-26.0% · median -321.7%

Net margin-31.5% · median -407.3%

Advertisement
300 × 250

See a number that looks wrong?